Staphylococcus aureus tagged posts

Closing in on a universal vaccine: Nasal spray protects mice from respiratory viruses, bacteria and allergens

Pulendran-universal-vax-square
Stanford Medicine researchers have developed an intranasal vaccine that protects mice against respiratory viruses, bacteria and allergens.
Chinamon/Adobe Stock

In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail—and about as elusive as a mythological vessel. But Stanford Medicine researchers and collaborators have taken an astonishing step forward in that quest, surprising even themselves.

In a new study in mice, they have developed a universal vaccine formula that protects against a wide range of respiratory viruses, bacteria and even allergens. The vaccine is delivered intranasally—such as through a nasal spray—and provides broad protection in the lungs for several months.

In the study, published in Sci...

Read More

‘Clever Drugs for Slimy Bugs’ in fight against Staph infections

PhD student Anthony Verderosa: Nitroxide functionalized antibiotics are promising eradication agents against Staphylococcus aureus biofilms

Bacterial biofilms that develop around golden staph infections make treatment difficult and prolonged, but researchers have shown in laboratory work that the hybrid antibiotics they have developed can destroy staph biofilms.

Eradicating deadly staph using a new breed of antibiotics has revealed promising results in research released by QUT, to help overcome one of the biggest modern medical challenges.

The bacteria attach to medical devices including catheters, artificial joints, implants and patients’ burns and wounds, establishing bacterial biofilms, a leading cause of failing antibiotic therapies and chronic infections.

QUT resear...

Read More

Boosting the Antibiotic Arsenal

1. Highlights • Quinolone antibiotics fail to kill bacterial populations at high density • Exhaustion of OXPHOS substrates drives bacterial persistence • Carbon and electron acceptor supplementation restores antibiotic activity • Metabolic priming of OXPHOS reverses tolerance in diverse bacterial species.  2.Sensitization to Cipro in Clinically Relevant Pathogens. 

MIT researchers have discovered a way to make bacteria more vulnerable to quinolones, which include ciprofloxacin and are often used to treat infections such as E coli and Staphylococcus aureus. The new strategy overcomes a key limitation of these drugs, which is that they often fail against infections that feature a very high density of bacteria...

Read More

Highly diluted Acetic acid Effective Alternative Agent to prevent infection and kill Bacteria in Burn Wounds

bacterial biofilm

bacterial biofilm

University of Birmingham and NIHR Surgical Reconstruction and Microbiology Research Centre (SRMRC) investigated antibacterial activity of acetic acid against key burn wound colonising organisms growing both planktonically and as biofilms.

Burns are a common traumatic injury and prone to becoming infected due to loss of a normal skin barrier. Local infection of the burn wound and subsequent sepsis are key concerns for patients, with sepsis the leading cause of death among patients with burn wounds. Infections of burn wounds are difficult to treat with traditional antibiotics as they do not effectively reach the wound, and the infecting organisms are often highly antibiotic resistant.

Low concentrations of acetic acid can be used to treat biofilms, and thus be used as alter...

Read More